Publications dans lesquelles il/elle collabore avec Rafael Golpe Gómez (24)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  2. Influence of physical activity on the prognosis of COPD patients: the HADO.2 score – health, activity, dyspnoea and obstruction

    ERJ Open Research, Vol. 10, Núm. 1

  3. Oxygen therapy could improve survival in patients with early desaturation in the 6-minute walk test: A post hoc analysis

    Respirology

2023

  1. A Novel Figure and Algorithm for the GOLD-ABE Classification: Additional Comments

    Archivos de Bronconeumologia

  2. Development and validation of a prognostic index (BODEXS90) for mortality in stable chronic obstructive pulmonary disease

    Pulmonology, Vol. 29, Núm. 4, pp. 276-283

  3. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

2022

  1. Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283

  2. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

  3. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  4. Effectiveness of CPAP vs. Noninvasive Ventilation Based on Disease Severity in Obesity Hypoventilation Syndrome and Concomitant Severe Obstructive Sleep Apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 228-236

  5. Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study

    Clinical Respiratory Journal, Vol. 16, Núm. 7, pp. 504-512

  6. Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. 451-453

  7. Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk

    Lung, Vol. 200, Núm. 5, pp. 601-607

2021

  1. Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC Guideline vs. GOLD

    Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 536-539

  2. Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?

    Archivos de Bronconeumologia

2020

  1. Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial

    Chest, Vol. 158, Núm. 3, pp. 1176-1186

2019

  1. Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial

    The Lancet, Vol. 393, Núm. 10182, pp. 1721-1732

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

2017

  1. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD

    The European respiratory journal, Vol. 50, Núm. 5

2016

  1. Mid- and Long-Term Efficacy of Non-Invasive Ventilation in Obesity Hypoventilation Syndrome: The Pickwick's Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 3, pp. 158-165